← Back to RNXT

RenovoRx, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 13/08/2026Mar 2026Filed 13/08/2026Sep 2025Filed 13/11/2025Jun 2025Filed 13/08/2026Mar 2025Filed 13/08/2026Sep 2024Filed 13/11/2025Jun 2024Filed 13/11/2025Mar 2024Filed 13/11/2025
$0.9$0.6$0.3$0.4$0.2
−$2.9−$3.5−$2.9−$2.9−$2.4−$2.5−$2.4−$1.1
−$0.06−$0.09−$0.08−$0.08−$0.08−$0.10−$0.10−$0.07
4738373731252415

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.